Genetic control of MHC class II expression

Cell

Volumn 109, Issue 2 SUPPL. 1, 2002, Pages

  Ting, Jenny Pan Yun ^a   Trowsdale, John ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Immunology Division   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DNA METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; ISOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; PROTEIN CIITA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; BARE LYMPHOCYTE SYNDROME; CHROMATIN; COMPLEX FORMATION; GENETIC REGULATION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0036239887     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00696-7     Document Type: Review

References (105)

1. The MHC class II transactivator: Prey and hunter in infectious diseases
2. Nonclassical MHC class II molecules
3. The mouse as a model for the effects of MHC genes on human disease
4. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes
5. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity
6. Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects
7. Sequence organisation of the class II region of the human MHC
8. Regulation of major histocompatibility complex class-II genes: X, Y, and other letters of the alphabet
9. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter
10. Analysis of the defect in IFN-γ induction of MHC class II genes in G1B cells: Identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor
11. NF-Y associates of H3-H4 tetramers and octamers by multiple mechanisms
12. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction
13. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II
14. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice
15. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB
16. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome
17. Mechanisms of nuclear import and export that control the subcellular localization of class ii transactivator
18. Assembly, transport and function of MHC class II molecules
19. Invariant chain structure and MHC class II function
20. Characterization of recombination in the HLA class II region
21. Genomics of the major histocompatibility complex: Haplotypes, duplication, retroviruses and disease
22. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter
23. The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes
24. Determination of the HLA-DM interaction site on HLA-DR molecules
25. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression
26. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains
27. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
28. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes
29. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon
30. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes
31. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells
32. Sequences and factors: A guide to MHC class-II transcription
33. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines
34. Cutting edge: The class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression
35. Polymorphism of the HLA class II loci in Siberian populations
36. The major histocompatibility complex of the rat (Rattus norvegicus)
37. A highly diverged beta 1 exon in the DR region of the human MHC: Sequence and evolutionary implications
38. CIITA leucine-rich repeats control nuclear localization, In vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation
39. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules
40. Class II transactivator: Mastering the art of major histocompatibility complex expression
41. The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator
42. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients
43. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans
44. Reduced IL-4-, lipopolysaccharide-, and IFN-γ-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain
45. Complex architecture of major histocompatibility complex class II promoters: Reiterated motifs and conserved protein-protein interactions
46. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex
47. Endogenous retroviral long terminal repeats within the HLA-DQ locus
48. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
49. In vivo footprinting of MHC class II genes: Bare promoter in the Bare Lymphocyte Syndrome
50. The NACHT family - A new group of predicted NTPases implicated in apoptosis and MHC transcription activation
51. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator
52. Self-association of class II transactivator correlates with its intracellular localization and transactivation
53. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules
54. Statins as a newly recognized type of immunomodulator
55. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression
56. Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: Mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines
57. Two distinct domains within CIITA mediate self-association: Involvement of the GTP-binding and leucine-rich repeat domains
58. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
59. Role of the CCAAT-binding protein CBF/NF-Y in transcription
60. The molecular biology of the CCAAT-binding factor NF-Y
61. Transfection of dendritic cells (DCs) with the CIITA gene: Increase in immunostimulatory activity of DCs
62. Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth
63. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
64. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex
65. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: Studies using NOD/CIITA-deficient mice
66. Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex
67. CREB regulates MHC class II expression in a CIITA-dependent manner
68. Methylation of class II trans-activator promoter IV: A novel mechanism of MHC class II gene control
69. Inhibition of IFN-γ signaling by an Epstein-Barr virus immediate-early protein
70. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation
71. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
72. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency
73. Class II transactivator is required for maximal expression of HLA-DOB in B cells
74. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome
75. Structure principles of MHC class II antigen presentation
76. Dendritic cell specific CIITA contains a caspase-recruitment domain that confers potent transactivation activity
77. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation
78. Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP
79. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta
80. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells
81. Regulation of class II expression in monocytic cells after hiv-1 infection
82. Genetic susceptibility to multiple sclerosis: Detection of polymorphic nucleotides and an intron in the 3′ untranslated region of the major histocompatibility complex class II transactivator gene
83. II250
84. The bare lymphocyte syndrome and the regulation of MHC expression
85. The chicken beta 2-microglobulin gene is located on a non-major histocompatibility complex microchromosome: A small, G+C-rich gene with X and Y boxes in the promoter
86. Antigen presentation: Kissing cousins exchange CLIP
87. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: Acquisition of antigen processing and presentation capacity
88. The structure of MHC class II: A role for dimer of dimers
89. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma
90. MHC class II regulation in vivo in the mouse kidney
91. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300
92. Self-association of CIITA and its transactivation potential
93. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes
94. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
95. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
96. Identification of class II transcriptional activator-induced genes by representational difference analysis: Discoordinate regulation of the DNα/DOβ heterodimer
97. The common regulatory pathway of MHC class I and class II transactivation
98. Doβ: A new β chain gene in hla-d with a distinct regulation of expression
99. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene
100. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer
101. Mice lacking the transcription factor CIITA - A second look
102. Mutation in the class II trans-activator leading to a mild immunodeficiency
103. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2
104. A 36-amino-acid region of CIITA is an effective inhibitor of CBP: Novel mechanism of gamma interferon-mediated suppression of collagen α(2)(I) and other promoters
105. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter